S Welt

2.9k total citations
37 papers, 2.4k citations indexed

About

S Welt is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, S Welt has authored 37 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in S Welt's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Radiopharmaceutical Chemistry and Applications (15 papers) and Glycosylation and Glycoproteins Research (9 papers). S Welt is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Radiopharmaceutical Chemistry and Applications (15 papers) and Glycosylation and Glycoproteins Research (9 papers). S Welt collaborates with scholars based in United States, Australia and Netherlands. S Welt's co-authors include Lloyd J. Old, E A Carswell, Andrew M. Scott, Steven M. Larson, L J Old, Herbert F. Oettgen, David M. Mintzer, M R Melamed, Carlos Cordon‐Cardo and Alan N. Houghton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

S Welt

37 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Welt United States 22 1.2k 1.0k 776 621 279 37 2.4k
Agamemnon A. Epenetos United Kingdom 30 1.4k 1.1× 1.1k 1.0× 665 0.9× 407 0.7× 250 0.9× 84 2.5k
M J Glennie United Kingdom 17 867 0.7× 857 0.9× 578 0.7× 764 1.2× 173 0.6× 25 2.2k
Rosalyn D. Blumenthal United States 32 1.6k 1.3× 862 0.9× 810 1.0× 284 0.5× 427 1.5× 95 2.9k
Paul J. Yazaki United States 33 1.7k 1.4× 1.3k 1.3× 1.1k 1.4× 461 0.7× 439 1.6× 102 3.4k
Maarten L. Janmaat Netherlands 17 726 0.6× 1.0k 1.0× 1.3k 1.6× 567 0.9× 525 1.9× 28 2.4k
Rhona Stein United States 35 1.8k 1.4× 866 0.9× 1.3k 1.7× 832 1.3× 383 1.4× 79 3.4k
David Flowers United States 20 647 0.5× 1.7k 1.7× 933 1.2× 524 0.8× 112 0.4× 43 3.2k
Kin-Ming Lo United States 27 789 0.6× 1.8k 1.8× 1.4k 1.8× 1.1k 1.7× 275 1.0× 43 3.5k
Graeme J. Dougherty United States 18 355 0.3× 741 0.7× 472 0.6× 603 1.0× 304 1.1× 44 2.0k
C. Thomas Powell United States 22 567 0.5× 1.3k 1.3× 612 0.8× 249 0.4× 1.0k 3.6× 33 2.5k

Countries citing papers authored by S Welt

Since Specialization
Citations

This map shows the geographic impact of S Welt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Welt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Welt more than expected).

Fields of papers citing papers by S Welt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Welt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Welt. The network helps show where S Welt may publish in the future.

Co-authorship network of co-authors of S Welt

This figure shows the co-authorship network connecting the top 25 collaborators of S Welt. A scholar is included among the top collaborators of S Welt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Welt. S Welt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kostyal, David, et al.. (2011). Trastuzumab and lapatinib modulation of HER2 tyrosine/threonine phosphorylation and cell signaling. Medical Oncology. 29(3). 1486–1494. 8 indexed citations
2.
Deckert, P. Markus, Christoph Renner, Lawrence Cohen, et al.. (2003). A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy. British Journal of Cancer. 88(6). 937–939. 31 indexed citations
3.
Hannah, Anthony, Robert Jones, Diane Hopkins, et al.. (1998). Dosimetric analysis of biodistribution and tumour uptake of I-131 huA33 in patients with colorectal carcinoma. Australian and New Zealand Journal of Medicine. 28(3). 369. 1 indexed citations
4.
Barendswaard, E, Andrew M. Scott, C R Divgi, et al.. (1998). Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.. International Journal of Oncology. 12(1). 45–53. 21 indexed citations
5.
Catimel, Bruno, Andrew M. Scott, Nobuo Hanai, et al.. (1998). Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterization. Glycobiology. 8(9). 927–938. 20 indexed citations
6.
Catimel, Bruno, Maureen Nerrie, Andrew M. Scott, et al.. (1997). Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. Journal of Chromatography A. 776(1). 15–30. 72 indexed citations
7.
Catimel, Bruno, Gerd Ritter, S Welt, et al.. (1996). Purification and Characterization of a Novel Restricted Antigen Expressed by Normal and Transformed Human Colonic Epithelium. Journal of Biological Chemistry. 271(41). 25664–25670. 44 indexed citations
8.
Garin‐Chesa, Pilar, Junichi Sakamoto, S Welt, et al.. (1996). Organ-specific expression of the colon cancer antigen A33, a cell surface target for antibody-based therapy. International Journal of Oncology. 9(3). 465–71. 76 indexed citations
9.
King, DJ, Pari Antoniw, Raymond J. Owens, et al.. (1995). Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy. British Journal of Cancer. 72(6). 1364–1372. 68 indexed citations
10.
Welt, S, Chaitanya Divgi, Nancy E. Kemeny, et al.. (1994). Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.. Journal of Clinical Oncology. 12(8). 1561–1571. 89 indexed citations
11.
Kitamura, K, Elisabeth Stockert, Pilar Garin‐Chesa, et al.. (1994). Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.. Proceedings of the National Academy of Sciences. 91(26). 12957–12961. 92 indexed citations
12.
Welt, S, C R Divgi, Andrew M. Scott, et al.. (1994). Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.. Journal of Clinical Oncology. 12(6). 1193–1203. 205 indexed citations
13.
Oosterwijk, Egbert, Neil H. Bander, C R Divgi, et al.. (1993). Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.. Journal of Clinical Oncology. 11(4). 738–750. 141 indexed citations
14.
Finstad, Connie L., Beatrice W.T. Yin, Claudia Gordon, et al.. (1991). Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis.. Journal of Histochemistry & Cytochemistry. 39(12). 1603–1610. 40 indexed citations
15.
Rivoire, Michel, et al.. (1990). Radioimmunodetection of hepatic metastases from human colon cancer in nude mice with a gamma-detecting probe.. PubMed. 50(3 Suppl). 877s–879s. 5 indexed citations
16.
Real, Francisco X., et al.. (1988). IFN- gamma -regulated expression of a differentiation antigen of human cells.. The Journal of Immunology. 140(5). 1571–1576. 6 indexed citations
17.
Chapman, Paul B., E. S. Casper, Janice Gabrilove, et al.. (1987). Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.. Journal of Clinical Oncology. 5(12). 1942–1951. 183 indexed citations
18.
Welt, S, M. Jules Mattes, Timothy M. Thomson, et al.. (1987). Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu mice.. Proceedings of the National Academy of Sciences. 84(12). 4200–4204. 35 indexed citations
19.
Welt, S, et al.. (1986). A molecular mechanism of complement resistance of human melanoma cells.. The Journal of Immunology. 136(7). 2534–2541. 23 indexed citations
20.
Welt, S, H. G. Purchase, & G. J. Thorbecke. (1977). Viral protein synthesis by tissues from avian leukosis virus-infected chickens. I. Susceptible chickens infected after hatching.. PubMed. 119(5). 1800–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026